Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiphospholipid Syndrome: State of the Art of Clinical Management.
Depietri L, Veropalumbo MR, Leone MC, Ghirarduzzi A. Depietri L, et al. Among authors: ghirarduzzi a. Cardiovasc Drugs Ther. 2023 Aug 12. doi: 10.1007/s10557-023-07496-3. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37572208 Review.
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.
Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators. Palareti G, et al. Among authors: ghirarduzzi a. Blood. 2014 Jul 10;124(2):196-203. doi: 10.1182/blood-2014-01-548065. Epub 2014 May 30. Blood. 2014. PMID: 24879813 Free article. Clinical Trial.
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey.
Pengo V, Del Ross T, Tonello M, Andreoli L, Tincani A, Gresele P, Silvestri E, Simioni P, Campello E, Hoxha A, Falanga A, Ghirarduzzi A, Denas G; COVID-19 APS collaborators. Pengo V, et al. Among authors: ghirarduzzi a. Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI136-SI142. doi: 10.1093/rheumatology/keac224. Rheumatology (Oxford). 2022. PMID: 35412604 Free PMC article.
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.
Pengo V, Hoxha A, Andreoli L, Tincani A, Silvestri E, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Denas G. Pengo V, et al. Among authors: ghirarduzzi a. J Thromb Haemost. 2021 Feb;19(2):531-535. doi: 10.1111/jth.15158. Epub 2020 Nov 29. J Thromb Haemost. 2021. PMID: 33128325 Free article. Clinical Trial.
118 results